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can produce similar airway cast for-
mation in humans; severe respiratory 
distress reﬂ  ects extensive obstruction 
of the respiratory system.
Healthcare providers should be 
aware of the possibility of bronchial 
casts when examining children with 
inﬂ  uenza (H1N1) infection accompa-
nied by atelectasis. Steroids can be ad-
ministered early in infection to avoid 
cast formation, and antiviral drug 
therapy and respiratory support can be 
used for inﬂ  uenza  (H1N1)–infected 
children in whom airway casts have 
developed.
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Methicillin-
Resistant 
Staphylococcus 
aureus ST398, Italy
To the Editor:  It has recently 
become apparent that livestock can 
constitute a new methicillin-resis-
tant Staphylococcus aureus (MRSA) 
reservoir and be a source of a novel 
and rapidly emerging type of MRSA. 
These livestock-associated MRSA 
clones are nontypeable by use of 
pulsed-ﬁ  eld gel electrophoresis with 
SmaI and belong to sequence type 
(ST) 398 (1). MRSA ST398 clones 
account for 20% of all MRSA in the 
Netherlands (2), but the emergence of 
such clones has been described world-
wide (3). Although ST398 transmis-
sion has been reported primarily 
between animals, persons with occu-
pational exposure to livestock are at 
higher risk for MRSA carriage than 
the general population. Even though 
MRSA ST398 usually causes coloni-
zation, several cases of infections of 
variable clinical relevance, varying 
from skin and soft tissue infections 
(4) to endocarditis (5) and pneumonia 
(6), have been described over the past 
few years. Most instances of ST398 
human carriers have been identiﬁ  ed 
among persons who work at pig farms 
(7). Data regarding MRSA coloniza-
tion of dairy farmers are less exhaus-
tive and, to our knowledge, only 1 in-
stance of direct transmission between 
cattle and humans has been proven. 
MRSA isolates from cows with sub-
clinical mastitis in 2007 in Hungary 
were indistinguishable from MRSA 
isolates from the tonsil swab of a 
farmer who worked with these ani-
mals (8). We report a case of MRSA 
ST398 invasive disease in a cattle 
farmer, as well as a case of MRSA 
ST398 necrotizing fasciitis. 
In early April 2008, a 52-year-old 
man was admitted to an intensive care 
unit in Manerbio, Italy, because of se-
vere sepsis and a large ulcerative and 
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suppurative lesion on the right side of 
his neck. His medical history was un-
remarkable. He was a worker at a dairy 
farm, was obese, and did not report any 
previous contact with the healthcare 
system. At the time of hospital admis-
sion, he was oriented and cooperative. 
His temperature was 38.4°C, heart rate 
was 125 beats per minute, and blood 
pressure was 165/75 mm Hg. Arterial 
blood gas analysis showed hypoxemia 
and mild hypocapnia (PaO2 53 mm Hg 
and PaCO2 33.8 mm Hg on room air). 
Leukocyte count was 21,280 cells/μL 
(81.9% polymorphonuclear cells), and 
platelet count was 310,000 cells/μL. 
After blood samples were collected 
and aggressive surgical debridement 
of affected tissue was performed, 
empirical treatment with intravenous 
teicoplanin and imipenem was started. 
On the basis of histologic appearance 
of the intraoperative material and com-
puted tomography scan images, necro-
tizing fasciitis was diagnosed. Culture 
of blood and necrotic tissue yielded 
MRSA. On day 3 after admission, an-
timicrobial drug therapy was changed 
to teicoplanin and clindamycin and, on 
day 7, to linezolid. Fever resolved in 3 
days and the patient’s condition pro-
gressively improved. The patient was 
discharged after 31 days of antimicro-
bial drug therapy. The MRSA isolate 
was susceptible to all the non–β-lactam 
antimicrobial drugs tested (excluding 
tetracycline), carried the staphylococ-
cal cassette chromosome mec type V, 
and was negative for Panton-Valentine 
leukocidin (PVL) genes. Multilocus 
sequence typing and sequence typing 
of the tandem repeat region of protein 
A gene (spa typing) showed that the 
isolate belonged to ST398 and spa 
type 899, respectively.
Some issues are of concern. Al-
though the MRSA isolate was PVL 
negative, its virulence resembled that 
of PVL-positive strains. Furthermore, 
it was resistant to tetracycline, as we 
expected because oxytetracyclines 
are the antimicrobial drugs most fre-
quently used in pig and cattle farming 
(3). The major limitation of our study 
was that data regarding MRSA colo-
nization of the farm are missing, so 
cattle-to-human transmission cannot 
be proven. However, because our pa-
tient did not have any other potential 
risk factor, dairy cows were probably 
the source of the human infection. In 
countries where community-acquired 
MRSA is common, all patients with 
serious S. aureus infections should be 
treated for MRSA until antimicrobial 
susceptibilities are known. Our report 
suggests that even in countries where 
community-acquired MRSA is still 
rare, being a cattle farmer may be con-
sidered an indication for early treat-
ment against MRSA.
The expanding knowledge of this 
zoonotic potential may undermine ex-
isting nosocomial MRSA control pro-
grams. In countries where a search and 
destroy policy (9) is adopted, such as 
the Netherlands, pig and cattle farm-
ers may warrant screening and isola-
tion at the time of hospital admission. 
Nevertheless, the ﬁ  rst MRSA ST398 
nosocomial outbreak has already been 
described (10).
It is difﬁ  cult to prevent persons 
with constant exposure to MRSA in 
their work or home setting from be-
coming MRSA carriers. Revisiting 
policies for the use of antimicrobial 
drugs on livestock farms, as well as 
improving hygiene measures, may 
therefore be necessary in infection 
control programs. However, before 
ﬁ  nal recommendations can be made, 
further investigation is needed to 
determine the prevalence of MRSA 
among livestock and their handlers.
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Neisseria 
meningitidis 
Serogroup W135, 
China 
To the Editor: Neisseria menin-
gitidis is a gram-negative bacterium 
found only in humans and is a major 
cause of serious invasive diseases. 
Before 2006, in the People’s Re-
public of China, all meningococcal 
diseases were caused by serogroups 
A, B, and C. However, there are >13 
serogroups of this organism. Three 
cases of infection with N. meningiti-
dis serogroup W135 were reported 
in China during 2006–2008. We de-
scribe these 3 meningitis patients and 
the N. meningitidis serogroup W135 
strains isolated from these patients by 
genotyping methods.
Patient 1, a 36-year-old man, 
was seen at a local hospital in Fujian 
Province in January 2006. He became 
ill while on a business trip and was 
given a diagnosis by culture of an N. 
meningitidis infection. Patient 2, a 
25-year-old man, was seen in Guang-
dong Province in May 2007. He had 
not traveled outside this area in the 10 
days before becoming ill. Patient 3, a 
14-year-old girl, was seen in Guangxi 
Province in February 2008. She was a 
middle school student and had toured 
the suburbs of this province with her 
classmates 2 days before becoming 
ill. Close contacts of all 3 patients 
were investigated; no additional N. 
meningitidis infections were detect-
ed. However, N.  meningitidis was 
isolated from a throat swab specimen 
obtained from the younger cousin of 
patient 3.
N. meningitidis infection was con-
ﬁ  rmed for all 3 patients on the basis of 
clinical symptoms and laboratory re-
sults. All patients reported neck stiff-
ness. Physical examinations showed 
Kernig signs, Brudzinski signs, and 
high temperatures (>38°C). Cerebro-
spinal ﬂ  uid (CSF) samples were turbid 
with increased protein levels and pres-
sure; leukocyte counts were increased 
(>5,000 cells/μL). CSF culture on 
chocolate agar grew N. meningitidis 
after 24 h. Isolates were identiﬁ  ed as 
serogroup W135 by using speciﬁ  c an-
tiserum (Remel, Lenexa, KS, USA) at 
provincial Centers for Disease Control 
and Prevention (CDC) in China and 
conﬁ  rmed at the Chinese CDC.
Patients were treated with anti-
microbial drugs and recovered fully. 
An isolate from the cousin of patient 
3 was also identiﬁ  ed as W135. Etest 
strips and broth microdilution were 
used for antimicrobial drug suscepti-
bility testing for the 4 W135 isolates. 
All isolates were susceptible to 12 an-
timicrobial drugs tested, which includ-
ed therapeutic and prophylaxis agents 
used frequently in China.
Pulsed-ﬁ   eld gel electrophoresis 
(PFGE), multilocus sequence typing, 
and outer membrane protein (porA) 
gene variant region subtyping were 
used to characterize the 4 case-related 
W135  N.  meningitidis isolates and 
other isolates from asymptomatic car-
riers. Strain R29057 (from France) 
was used as a reference strain. The 4 
case-related isolates showed similar 
PFGE patterns. These patterns were 
distinct from those of other W135 iso-
lates obtained from asymptomatic car-
riers. Three invasive disease isolates 
and 1 from the close contact of patient 
3 had the same multilocus sequence 
type (ST) and PorA subtype; all were 
ST11: P1.5, 2. This subtype was not 
detected among other tested isolates 
of W135 obtained from asymptomatic 
carriers (online Technical Appendix, 
www.cdc.gov/EID/content/16/2/348-
Techapp.pdf).
ST11: P1.5, 2 N.  meningitidis 
serogroup W135 was responsible for 
the epidemic of W135 meningococcal 
disease in 2000, which was associated 
with the Hajj pilgrimage in Saudi Ara-
bia (1,2). The strain related to the Hajj 
pilgrimage was derived from clonal 
expansion within the ST11 complex/
ET-37 complex (3). However, no epi-
demiologic data showed that the 3 
cases in our study were linked to the 
Hajj pilgrimage. Since 2000, invasive 
diseases caused by W135 meningo-
cocci of ST11 have been reported in 
Africa, Asia, and the Middle East (4). 
ST11 W135 infections have been re-
ported to cause invasive disease in 
Taiwan during 1996–2002 and were 
apparently introduced into Taiwan 
before the Hajj pilgrimage–associated 
outbreak because they were genotypi-
cally distinct from the Hajj-related 
W135 clone (5,6).
The 3 cases we report were ob-
served in southeastern China near 
Taiwan (online Technical Appendix), 
but no direct epidemiologic links 
are known. Because of the lack of 
W135 strains from Hajj pilgrimages 
and Taiwan in this study, we could 
not provide a detailed and integrated 
genotypic relationship between the 
strains in China and those of Hajj pil-
grimages and Taiwan. However, we 
can conﬁ  rm that these 3 cases were 
caused by strains from the same hy-
pervirulent clone characterized as 
ST11: P1.5, 2.
W135 strains have been isolat-
ed after vaccination with a bivalent 
meningococcal vaccine in Cameroon 
(7). In China, the bivalent meningo-
coccal vaccine has been successfully 
introduced into the national expanded 
immunization program in response 
to an outbreak of N. meningitidis se-
rogroup C during 2003–2004 (8).
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